Aurinia Pharmaceuticals Showcases LUPKYNIS’s Impact at ASN 2024
PremiumCompany AnnouncementsAurinia Pharmaceuticals Showcases LUPKYNIS’s Impact at ASN 2024
30d ago
Aurinia’s Lupus Drug LUPKYNIS Wins Approval in Japan
Premium
Company Announcements
Aurinia’s Lupus Drug LUPKYNIS Wins Approval in Japan
2M ago
Aurinia Pharmaceuticals announces Japan MHLW approval for voclosporin
Premium
The Fly
Aurinia Pharmaceuticals announces Japan MHLW approval for voclosporin
2M ago
Aurinia Pharmaceuticals doses first participant in AUR200 trial
PremiumThe FlyAurinia Pharmaceuticals doses first participant in AUR200 trial
2M ago
Aurinia Pharmaceuticals call volume above normal and directionally bullish
Premium
The Fly
Aurinia Pharmaceuticals call volume above normal and directionally bullish
2M ago
Aurinia Pharmaceuticals call volume above normal and directionally bullish
Premium
The Fly
Aurinia Pharmaceuticals call volume above normal and directionally bullish
3M ago
Aurinia Pharmaceuticals (AUPH) Q2 Earnings Cheat Sheet
PremiumPre-EarningsAurinia Pharmaceuticals (AUPH) Q2 Earnings Cheat Sheet
3M ago
Aurinia Pharmaceuticals Announces Q2 Results Date
Premium
Company Announcements
Aurinia Pharmaceuticals Announces Q2 Results Date
4M ago
Aurinia Pharmaceuticals Engages Investors at Key Conferences
Premium
Company Announcements
Aurinia Pharmaceuticals Engages Investors at Key Conferences
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100